Blake Jeffrey Grayson Sells 9,515 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 9,515 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total transaction of $650,159.95. Following the completion of the sale, the chief financial officer owned 118,213 shares in the company, valued at $8,077,494.29. This represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Blake Jeffrey Grayson also recently made the following trade(s):

• On Wednesday, October 1st, Blake Jeffrey Grayson sold 6,500 shares of Docusign stock. The stock was sold at an average price of $71.20, for a total value of $462,800.00.

Docusign Stock Performance

DOCU stock opened at $69.40 on Friday. The stock’s 50 day moving average price is $68.93 and its 200 day moving average price is $74.18. The firm has a market cap of $13.90 billion, a P/E ratio of 48.53, a PEG ratio of 3.40 and a beta of 0.98. Docusign Inc. has a 1 year low of $63.41 and a 1 year high of $99.30.

Analyst Ratings Changes

A number of research firms recently commented on DOCU. Wedbush decreased their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Wall Street Zen raised shares of Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Robert W. Baird lowered their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Argus reissued a “hold” rating on shares of Docusign in a research note on Monday, September 8th. Finally, BTIG Research started coverage on shares of Docusign in a research report on Tuesday. They set a “buy” rating and a $88.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $86.80.

Institutional Investors Weigh In On Docusign

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its position in Docusign by 1.1% during the third quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock worth $1,558,986,000 after purchasing an additional 225,525 shares during the last quarter. State Street Corp boosted its holdings in shares of Docusign by 0.5% in the 3rd quarter. State Street Corp now owns 8,116,797 shares of the company’s stock valued at $585,140,000 after purchasing an additional 41,821 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Docusign by 1.6% during the 2nd quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock valued at $433,405,000 after buying an additional 86,560 shares during the period. Geode Capital Management LLC increased its holdings in shares of Docusign by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company’s stock worth $309,910,000 after buying an additional 59,941 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Docusign by 4.5% during the 3rd quarter. Invesco Ltd. now owns 2,690,121 shares of the company’s stock worth $193,931,000 after buying an additional 116,047 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.